Finally, we tested CYC065 in an established transgenic model of NB, in which coexpression of hyperactivated anaplastic lymphoma kinase (ALKF1174L, a clinical mutation that cosegregates with MYCN amplification in NB patients) drives transcriptional activation of MYCN and formation of aggressive NB (37). Here, ALK is linked to neuroblastoma.